Mohammad Al Nahedh has been appointed as the Oncology Medical Head at Novartis and shared the announcement on LinkedIn:
“I’m happy to share that I’m starting a new position as Oncology Medical Head at Novartis!”
About Mohammad Al Nahedh
Mohammad Al Nahedh is an oncology leader, clinical pharmacy consultant, and healthcare executive specializing in hematology and medical oncology.
Prior to his appointment as Oncology Medical Head at Novartis, he served as the Director of the Pharmaceutical Care Division and Clinical Pharmacy Consultant in Hematology/Oncology at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia.
He holds leadership roles in professional oncology associations, including serving on the Board of Directors of the Saudi Oncology Pharmacy Society (SOPS).
You can also read:
Novartis’ $1.5B Myricx deal is a preclinical bet on a brand-new ADC payload
